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Abstract — Lead (Pb) is a toxic metal, which widespread use 
has resulted in environmental contamination, human exposure 
and significant public health problems. The autonomic nervous 
system, being a homeostatic controller, is impaired in acute and 
chronic lead exposure. In fact, sympathoexcitation associated to 
hypertension and tachypnea has been described together with 
baroreflex and chemoreflex dysfunction. However, up to date, no 
studies described the autonomic effects of an intermittent low-
level lead exposure. In the present work, we addressed in vivo, 
autonomic behaviour in rats under chronic Pb exposure 
(control) and in rats under intermittent Pb exposure. For that, 
arterial blood pressure (BP) and ECG were recorded in 28 
weeks old animal and low frequencies (LF) and high frequencies 
(HF) were determined (to estimate sympathetic and 
parasympathetic activities) using FisioSinal software with 
Wavelet module. Our preliminary results depict that 
intermittently lead-exposed rats show a significant decrease in 
systolic BP, without significant changes on LF, HF and LF/HF 
bands, when compared to chronically Pb- exposed rats. 
 
Our data suggests that the autonomic dysfunction induced by 
lead exposure is similar in a chronic and intermittent Pb 
exposure. Nevertheless, it seems that an intermittent exposure 
was no effect on systolic BP values. 
The present study brings new insights on the environmental 
factors that influence autonomic and cardiovascular systems 
during development, which can help apprise public policy 
strategies to prevent and control the adverse effects of Pb 
toxicity. 
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I. INTRODUCTION 
Lead is the most commonly used heavy metal worldwide for 
over 8000 years in a large amount of industries like 
automobiles, ceramics, paint, plastics, among others, in behalf 
of its unique properties such as high malleability, low melting 
point, softness, ductility and resistance to corrosion[1], [2]. 
Regarding this wide usage, it is obvious that there is a rise 
in environmental free lead and its occurrence in biological 
systems concerning the non-biodegradable nature of this 
heavy metal.  
Lead toxicity, due to its ingestion, inhalation or, less 
probably by direct contact, can evoke irreversible effects in a 
wide amount of body functions affecting mainly the 
cardiovascular [3], [4] (being one of the causes of 
hypertension and promoting atherosclerosis, thrombosis, 
arteriosclerosis and cardiovascular disease) , 
hematopoietic[1], [5], reproductive[6] (both, in woman and 
men, leading to misscariage, inferitility and premature 
delivery in women and reduction of libido, abnormal 
spermatogenesis and infertility in men), [7] and renal (leading 
to acute and chronic nephropathy, by molecular and tubular 
changes) [8] systems. 
Being easily accumulated in bone and soft tissues, and due 
to the ability of lead to cross the blood brain barrier and to 
substitute cations like Ca2+, Mg2+, Fe2+ and Na2+, lead is 
also a neurotoxin. These alterations, induce changes in the 
neurogenesis, especially when the exposure happens in the 
early stages of life, neurodegeneration and changes on glial 
cells, that support neurons and play a crucial role in synaptic 
transmission and plasticity. The changes in the molecular and 
cellular processes lead to cognitive and behaviour alterations, 
particularly during developmental phases, persisting during 
the lifetime. [1], [9], [10]  
Additionally, regarding the autonomic tone, that regulates 
the cardiorespiratory processes, the exposure to toxic levels 
of lead produce a significant increase in sympathetic activity 
associated to high blood pressure, decreased baroreflex 
function, increased chemoreceptor sensitivity and tachypnoea 
[11]. 
Two types of lead toxicity could be defined. Firstly, acute 
toxicity, usually in high-levels, is quite uncommon and 
happens by occupational exposure, while chronic low-level 
exposure toxicity is more common, happening in a household 
environment and much severe if not treated in time.  
However, up to date, no studies were performed to establish 
the autonomic effects in an intermittent low-level lead 
exposure. This type of exposure is increasing due to the 
augmented migration and to the implementation of school 
exchange programs. Nevertheless, people tend to come back 
to their hometowns after some years abroad, returning to their 
familiar environment. Additionally, in workplaces where the 
use of lead is recurrent, rotation of workers and moving of 
these to other workplaces without lead exposure has been 
performed during the past years as a possible prevention of 
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adverse health effects caused by occupational permanent low-
level lead exposure.  
Therefore, our work is focused on studying the autonomic 
changes provoked by a newintermittent low-level lead 
exposure profile.The section II (methods) describe the design 
of the present study, including the development of two animal 
models and provide a description of the procedures that were 
performed.for the autonomic evaluation. The preliminary 
results obtained in our study are presented in the section III 
and then discussed, comparing our results with other 
published evidence in section IV. Some final, summative 
statements, based upon our findings are reported in section V: 
  
II. METHODS 
A. Development of the animal model of chronic and 
intermittent lead exposure 
Seven-day pregnant Wistar rats (n = 2) were exposed to 
lead during pregnancy, via water containing Lead acetate 
(0.2% w/v) that replaced tap water. After birth and weaning at 
21 days, the rats of both sexes were exposed to the same lead 
solution as that of their mother and were divided into 2 
groups (n = 6/group; Pb1 – used as control group – and Pb2). 
At 12 weeks, the intake of the solution ended in both groups; 
and this was followed by a period without exposure that 
lasted up to 20 weeks. The Pb2 group underwent a second 
exposure which lasted 8 weeks (named intermittent lead 
exposure group) while Pb1 wasn’t exposed to lead for the 
second time (named chronic lead exposure group).  
 
B. Surgical protocol 
At 28 weeks, the acute experiment was carried out in both 
groups of animals (n=12). Animals of both sexes were 
anesthetized with sodium pentobarbital (60mg/kg, ip). The 
femoral artery and vein were cannulated for blood pressure 
monitoring and injection of saline and drugs, respectively. 
Rectal temperature was maintained between 36.5-39ºC. The 
electrocardiogram (ECG) was recorded with subcutaneous 
electrodes inserted in three of the four members and heart rate 
was also obtained through this registration method (Neurolog, 
Digitimer[12]).  
 
C. Data acquisition  
Signals were amplified with the alternative current pre 
amplifier gain of 5K and a high-pass filter of 0.1Hz, filtered 
by band-pass filter of 500-5000Hz and a 20Hz wave width 
(Neurolog, Digitimer) and acquired at 1 kHz (PowerLab, 
ADInstruments[13]). All signals were converted to digital 
form and stored for further analysis. 
 
D. Analysis of heart rate and systolic blood pressure 
variability 
Using FisioSinal [14], an in-house developed software with 
Wavelet module (Db12)[15], [16], the LF, HF and LF/HF 
indexes were determined in basal conditions.  Low 
frequencies (LF; 0.15-0.6 Hz) that were obtained from 
systolic BP are a marker of sympathetic activity, high 
frequencies (HF; 0.6-2.0 Hz) attained from R-R interval 
represent both parasympathetic and respiratory variations, 
and LF/HF is the ratio between sympathetic and 
parasympathetic systems. In this study and to the fact that the 
respiratory rate was high in some animals, we proceeded to an 
adjustment of the high frequencies band while maintaining its 
lower end and extending to its upper limit to 2.4 Hz.  
 
E. Statistical analysis 
Variables are expressed as mean and SEM. Statistical data 
was obtained by comparisons between groups of animals – 
Pb1 and Pb2 – using Student’s t-test. Significance was 
considered to p<0.05. Data was analysed using GraphPad 
Prism 6 software[17] (GraphPad Software, Inc., USA). 
III. RESULTS 
A. Cardiovascular variables and autonomic tone 
Baseline levels of all measured physiological parameters 
were similar between the 2 groups, except for systolic blood 
pressure with significantly higher values in Pb1-rats 
compared with Pb2-rats as shown in Table 1.  
 
TABLE 1 
BASELINE LEVELS OF ALL MEASURED PHYSIOLOGICAL PARAMETERS. 
BP, BLOOD PRESSURE; HR, HEART RATE; RF, RESPIRATORY 
FREQUENCY 
Values presented as MEAN ± SEM (n=6), ap<0.05 
Group Pb1 Pb2 
Mean BP 
(mmHg2) 
125 ± 4 116 ± 3 
Systolic BP 
(mmHg2)  
144 ± 3 a 126 ± 4 
Diastolic BP 
(mmHg2) 
110 ± 5 106 ± 3 
Basal HR 
(bpm) 
371 ± 8 404 ± 17 
Basal RF 
(cpm) 
56 ± 4 58 ± 5 
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 The sympathetic and parasympathetic tone evaluated 
through LF and HF band, respectively, as well as LF/HF band 
presenting the ratio between sympathetic and parasympathetic 
systems (1.5 ± 0.3 vs 1.7 ± 0.5 mmHg2, 1.9 ± 0.7 vs 2.8 ± 1.2 
bpm2 and 1.2 ± 0.4 vs 1.1 ± 0.3 mmHg2/bpm2, respectively) 
didn´t change significantly between the 2 groups, as shown in 
figure 1, 2, and 3, respectively, for each band.  
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Figure 1. Sympathetic activity presented by LF (Low Frequencies) 
band for each group. No significant difference in LF band values 
was observed in the Pb2 group – intermittent lead exposure (1.7 ± 
0.5 mmHg2) when compared to the Pb1 group – chronic lead 
exposure (1.5 ± 0.3 mmHg2). Values presented as MEAN ± SEM 
(n=6). 
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Figure 2. Parasympathetic activity presented by HF (High 
Frequencies) band for each group. No significant difference was 
detected in HF band of the Pb2 group - intermittent lead exposure 
(2.8 ± 1.2 bpm2) when correlated to the Pb1 group - chronic lead 
exposure (1.9 ± 0.7 bpm2). Values presented as MEAN ± SEM 
(n=6). 
 
Figure 3. Ratio between sympathetic and parasympathetic systems 
presented by LF/HF band values. No significant difference between 
LF/HF band of the Pb2 group – intermittent lead exposure (1.1 ± 
0.3 mmHg2/bpm2) and the Pb1 group - chronic lead exposure (1.2 ± 
0.4 mmHg2/bpm2) was distinguished. Values presented as MEAN ± 
SEM (n=6). 
IV. DISCUSSION 
The current study is the first to address a new profile of lead 
exposure, the intermittent low-level lead exposure. Our 
reported results demonstrate that the autonomic effects of this 
type of exposure are similar to the chronic lead exposure, 
since we didn´t find differences in sympathetic and 
parasympathetic tones between the two types of exposure, 
providing an association between the autonomic function and 
lead intoxication, regardless of the type of lead exposure.  
In relation to the other physiological parameters evaluated, 
i.e. blood pressure, heart rate and respiratory frequency, all 
are similar except for systolic blood pressure that is 
significantly decreased in the intermittent lead exposure 
group (Pb2) (126 ± 4 mmHg2) when compared to the chronic 
lead exposure group (144 ± 3 mmHg2). The decrease on 
arterial compliance, which is used as an indication of arterial 
stiffness, provoked by a chronic lead toxicity may be the 
reason for the increased systolic blood pressure recorded in 
the chronic lead exposure group (Pb1). 
Even though autonomic function is not known to be primarily 
affected by chronic lead exposure, the autonomic nervous 
system has been found compromised by Pb-poisoning, 
causing an overall autonomic dysfunction[11].  
Additionally, it was shown that lead reduces baroreflex 
sensitivity, vagal parasympathetic tone, and increases 
sympathetic activity, by impairment of dopamine and 
acetylcholine transmission, as well as oxidative stress induced 
by lead poisoning [18]–[20].  
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These reported effects - baroreflex hyposensitivity, 
sympathetic overexcitation and decreased parasympathetic 
tone - are associated with several pathologies such as 
hypertension, acute cardiac ischemia or even heart failure. 
The mechanisms underlying those pathological effects 
haven’t been clarified but it is thought that there is an initial 
protective reaction which in time, turns into deleterious 
sympathoexcitation [11].  
Here we present our preliminary results regarding the 
autonomic nervous system evaluation. These results indicate 
that the intermittent low-level lead exposure is associated 
with sympathetic hyperactivity, as already described for a 
chronic exposure, but with no effect on blood pressure values, 
since in the intermittent exposure the animals remain 
normotensive.  
Regarding the fact that our results are preliminary, more 
evaluations should be carried on, for a full characterization of 
the new animal model that was developed, using other 
electronic equipment, machinery and software’s (such as  
blood pressure and ECG telemetry)  or other molecular and 
physiological evaluations. These additional evaluations would 
be of extreme importance to better understand the underlying 
mechanisms of lead toxicity.  
V. CONCLUSION 
 
In conclusion, the present study brings new insights into how 
different lead poisoning profiles may influence autonomic 
and cardiovascular systems during developmental phases. 
Thus, helping to upraise public policy strategies to prevent 
and control the adverse effects of Pb toxicity.  
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